nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2B6—Irinotecan—stomach cancer	0.0967	0.268	CbGbCtD
Diphenhydramine—CYP2C9—Capecitabine—stomach cancer	0.0827	0.229	CbGbCtD
Diphenhydramine—CYP1A2—Fluorouracil—stomach cancer	0.0544	0.151	CbGbCtD
Diphenhydramine—CYP2B6—Doxorubicin—stomach cancer	0.0528	0.146	CbGbCtD
Diphenhydramine—CYP2C9—Fluorouracil—stomach cancer	0.049	0.136	CbGbCtD
Diphenhydramine—CYP2D6—Doxorubicin—stomach cancer	0.0255	0.0707	CbGbCtD
Diphenhydramine—CYP2C18—digestive system—stomach cancer	0.00317	0.0572	CbGeAlD
Diphenhydramine—Asthenia—Floxuridine—stomach cancer	0.00297	0.00826	CcSEcCtD
Diphenhydramine—Somnolence—Mitomycin—stomach cancer	0.00289	0.00803	CcSEcCtD
Diphenhydramine—Diarrhoea—Floxuridine—stomach cancer	0.00283	0.00788	CcSEcCtD
Diphenhydramine—Decreased appetite—Mitomycin—stomach cancer	0.00282	0.00786	CcSEcCtD
Diphenhydramine—Fatigue—Mitomycin—stomach cancer	0.0028	0.00779	CcSEcCtD
Diphenhydramine—Feeling abnormal—Mitomycin—stomach cancer	0.00268	0.00745	CcSEcCtD
Diphenhydramine—Vomiting—Floxuridine—stomach cancer	0.00263	0.00732	CcSEcCtD
Diphenhydramine—Irritability—Fluorouracil—stomach cancer	0.00262	0.0073	CcSEcCtD
Diphenhydramine—CYP2C18—endocrine gland—stomach cancer	0.00262	0.0473	CbGeAlD
Diphenhydramine—Rash—Floxuridine—stomach cancer	0.00261	0.00726	CcSEcCtD
Diphenhydramine—Dermatitis—Floxuridine—stomach cancer	0.00261	0.00725	CcSEcCtD
Diphenhydramine—Headache—Floxuridine—stomach cancer	0.00259	0.00721	CcSEcCtD
Diphenhydramine—PTGS1—blood vessel—stomach cancer	0.00258	0.0465	CbGeAlD
Diphenhydramine—SLC22A2—digestive system—stomach cancer	0.00248	0.0447	CbGeAlD
Diphenhydramine—Neuritis—Epirubicin—stomach cancer	0.00247	0.00687	CcSEcCtD
Diphenhydramine—Nausea—Floxuridine—stomach cancer	0.00246	0.00684	CcSEcCtD
Diphenhydramine—Sweating increased—Irinotecan—stomach cancer	0.00242	0.00672	CcSEcCtD
Diphenhydramine—CYP2C18—liver—stomach cancer	0.00236	0.0426	CbGeAlD
Diphenhydramine—Asthenia—Mitomycin—stomach cancer	0.00233	0.00648	CcSEcCtD
Diphenhydramine—Neuritis—Doxorubicin—stomach cancer	0.00229	0.00636	CcSEcCtD
Diphenhydramine—Cinnarizine—HRH4—stomach cancer	0.00226	0.137	CrCbGaD
Diphenhydramine—Diarrhoea—Mitomycin—stomach cancer	0.00222	0.00618	CcSEcCtD
Diphenhydramine—Photosensitivity—Capecitabine—stomach cancer	0.00219	0.00609	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Fluorouracil—stomach cancer	0.00217	0.00603	CcSEcCtD
Diphenhydramine—Dizziness—Mitomycin—stomach cancer	0.00215	0.00598	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Capecitabine—stomach cancer	0.00213	0.00592	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Fluorouracil—stomach cancer	0.00208	0.00578	CcSEcCtD
Diphenhydramine—Vomiting—Mitomycin—stomach cancer	0.00207	0.00575	CcSEcCtD
Diphenhydramine—Rash—Mitomycin—stomach cancer	0.00205	0.0057	CcSEcCtD
Diphenhydramine—Dermatitis—Mitomycin—stomach cancer	0.00205	0.00569	CcSEcCtD
Diphenhydramine—Headache—Mitomycin—stomach cancer	0.00204	0.00566	CcSEcCtD
Diphenhydramine—Agranulocytosis—Fluorouracil—stomach cancer	0.00198	0.0055	CcSEcCtD
Diphenhydramine—Alverine—HTR1A—stomach cancer	0.00194	0.118	CrCbGaD
Diphenhydramine—CYP2C19—hematopoietic system—stomach cancer	0.00194	0.035	CbGeAlD
Diphenhydramine—Nausea—Mitomycin—stomach cancer	0.00193	0.00537	CcSEcCtD
Diphenhydramine—Diplopia—Capecitabine—stomach cancer	0.00192	0.00534	CcSEcCtD
Diphenhydramine—Irritability—Capecitabine—stomach cancer	0.00183	0.0051	CcSEcCtD
Diphenhydramine—Urinary retention—Capecitabine—stomach cancer	0.00183	0.00508	CcSEcCtD
Diphenhydramine—Chills—Irinotecan—stomach cancer	0.00178	0.00496	CcSEcCtD
Diphenhydramine—Photosensitivity—Methotrexate—stomach cancer	0.00163	0.00453	CcSEcCtD
Diphenhydramine—Sweating increased—Capecitabine—stomach cancer	0.00162	0.0045	CcSEcCtD
Diphenhydramine—Promethazine—HRH4—stomach cancer	0.00159	0.0965	CrCbGaD
Diphenhydramine—CYP1A2—hematopoietic system—stomach cancer	0.00158	0.0286	CbGeAlD
Diphenhydramine—Doxepin—HRH4—stomach cancer	0.00158	0.0955	CrCbGaD
Diphenhydramine—Vision blurred—Fluorouracil—stomach cancer	0.00156	0.00434	CcSEcCtD
Diphenhydramine—Vertigo—Irinotecan—stomach cancer	0.00155	0.00432	CcSEcCtD
Diphenhydramine—Dysuria—Capecitabine—stomach cancer	0.00155	0.00432	CcSEcCtD
Diphenhydramine—Photosensitivity—Epirubicin—stomach cancer	0.00152	0.00424	CcSEcCtD
Diphenhydramine—CYP2B6—hematopoietic system—stomach cancer	0.00152	0.0274	CbGeAlD
Diphenhydramine—Photosensitivity reaction—Capecitabine—stomach cancer	0.00152	0.00422	CcSEcCtD
Diphenhydramine—CYP2C9—hematopoietic system—stomach cancer	0.0015	0.0271	CbGeAlD
Diphenhydramine—Neuropathy peripheral—Docetaxel—stomach cancer	0.0015	0.00417	CcSEcCtD
Diphenhydramine—HRH1—hematopoietic system—stomach cancer	0.00148	0.0267	CbGeAlD
Diphenhydramine—CHRM2—endocrine gland—stomach cancer	0.00147	0.0265	CbGeAlD
Diphenhydramine—Neuropathy peripheral—Capecitabine—stomach cancer	0.00145	0.00404	CcSEcCtD
Diphenhydramine—SLC22A1—endocrine gland—stomach cancer	0.00144	0.0261	CbGeAlD
Diphenhydramine—Convulsion—Fluorouracil—stomach cancer	0.00143	0.00399	CcSEcCtD
Diphenhydramine—Agranulocytosis—Docetaxel—stomach cancer	0.00143	0.00397	CcSEcCtD
Diphenhydramine—Confusional state—Irinotecan—stomach cancer	0.00142	0.00396	CcSEcCtD
Diphenhydramine—Photosensitivity—Doxorubicin—stomach cancer	0.00141	0.00392	CcSEcCtD
Diphenhydramine—Agranulocytosis—Capecitabine—stomach cancer	0.00138	0.00384	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Irinotecan—stomach cancer	0.00138	0.00384	CcSEcCtD
Diphenhydramine—PTGS1—hematopoietic system—stomach cancer	0.00137	0.0248	CbGeAlD
Diphenhydramine—Irritability—Methotrexate—stomach cancer	0.00137	0.0038	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Irinotecan—stomach cancer	0.00136	0.00379	CcSEcCtD
Diphenhydramine—Confusional state—Fluorouracil—stomach cancer	0.00136	0.00379	CcSEcCtD
Diphenhydramine—HRH1—epithelium—stomach cancer	0.00135	0.0244	CbGeAlD
Diphenhydramine—CYP2C19—digestive system—stomach cancer	0.00135	0.0243	CbGeAlD
Diphenhydramine—Anorexia—Irinotecan—stomach cancer	0.00135	0.00374	CcSEcCtD
Diphenhydramine—Diplopia—Epirubicin—stomach cancer	0.00134	0.00372	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Fluorouracil—stomach cancer	0.00132	0.00368	CcSEcCtD
Diphenhydramine—Tachycardia—Fluorouracil—stomach cancer	0.00132	0.00367	CcSEcCtD
Diphenhydramine—Hypotension—Irinotecan—stomach cancer	0.00132	0.00367	CcSEcCtD
Diphenhydramine—HRH1—smooth muscle tissue—stomach cancer	0.00131	0.0235	CbGeAlD
Diphenhydramine—SLC22A1—liver—stomach cancer	0.0013	0.0235	CbGeAlD
Diphenhydramine—Anorexia—Fluorouracil—stomach cancer	0.00129	0.00358	CcSEcCtD
Diphenhydramine—Insomnia—Irinotecan—stomach cancer	0.00128	0.00355	CcSEcCtD
Diphenhydramine—Paraesthesia—Irinotecan—stomach cancer	0.00127	0.00352	CcSEcCtD
Diphenhydramine—Hypotension—Fluorouracil—stomach cancer	0.00126	0.00351	CcSEcCtD
Diphenhydramine—Somnolence—Irinotecan—stomach cancer	0.00125	0.00349	CcSEcCtD
Diphenhydramine—PTGS1—epithelium—stomach cancer	0.00125	0.0226	CbGeAlD
Diphenhydramine—Dyspepsia—Irinotecan—stomach cancer	0.00124	0.00345	CcSEcCtD
Diphenhydramine—Tinnitus—Capecitabine—stomach cancer	0.00124	0.00345	CcSEcCtD
Diphenhydramine—Diplopia—Doxorubicin—stomach cancer	0.00124	0.00344	CcSEcCtD
Diphenhydramine—Chills—Docetaxel—stomach cancer	0.00123	0.00343	CcSEcCtD
Diphenhydramine—Decreased appetite—Irinotecan—stomach cancer	0.00123	0.00341	CcSEcCtD
Diphenhydramine—Insomnia—Fluorouracil—stomach cancer	0.00122	0.0034	CcSEcCtD
Diphenhydramine—Amitriptyline—HRH4—stomach cancer	0.00122	0.0738	CrCbGaD
Diphenhydramine—Fatigue—Irinotecan—stomach cancer	0.00122	0.00338	CcSEcCtD
Diphenhydramine—SLC22A5—digestive system—stomach cancer	0.00122	0.0219	CbGeAlD
Diphenhydramine—Paraesthesia—Fluorouracil—stomach cancer	0.00121	0.00338	CcSEcCtD
Diphenhydramine—PTGS1—smooth muscle tissue—stomach cancer	0.00121	0.0218	CbGeAlD
Diphenhydramine—Constipation—Irinotecan—stomach cancer	0.00121	0.00336	CcSEcCtD
Diphenhydramine—Somnolence—Fluorouracil—stomach cancer	0.0012	0.00334	CcSEcCtD
Diphenhydramine—Chills—Capecitabine—stomach cancer	0.00119	0.00332	CcSEcCtD
Diphenhydramine—Dyspepsia—Fluorouracil—stomach cancer	0.00119	0.00331	CcSEcCtD
Diphenhydramine—Decreased appetite—Fluorouracil—stomach cancer	0.00117	0.00327	CcSEcCtD
Diphenhydramine—Feeling abnormal—Irinotecan—stomach cancer	0.00116	0.00323	CcSEcCtD
Diphenhydramine—Dysuria—Methotrexate—stomach cancer	0.00116	0.00322	CcSEcCtD
Diphenhydramine—Clomifene—CYP2A6—stomach cancer	0.00114	0.0689	CrCbGaD
Diphenhydramine—Photosensitivity reaction—Methotrexate—stomach cancer	0.00113	0.00314	CcSEcCtD
Diphenhydramine—CYP2D6—hematopoietic system—stomach cancer	0.00113	0.0203	CbGeAlD
Diphenhydramine—Feeling abnormal—Fluorouracil—stomach cancer	0.00111	0.0031	CcSEcCtD
Diphenhydramine—CYP2C19—endocrine gland—stomach cancer	0.00111	0.0201	CbGeAlD
Diphenhydramine—Drowsiness—Methotrexate—stomach cancer	0.0011	0.00307	CcSEcCtD
Diphenhydramine—CYP1A2—digestive system—stomach cancer	0.0011	0.0199	CbGeAlD
Diphenhydramine—Vision blurred—Capecitabine—stomach cancer	0.00109	0.00303	CcSEcCtD
Diphenhydramine—Tremor—Capecitabine—stomach cancer	0.00108	0.00302	CcSEcCtD
Diphenhydramine—Dysuria—Epirubicin—stomach cancer	0.00108	0.00301	CcSEcCtD
Diphenhydramine—Urticaria—Fluorouracil—stomach cancer	0.00107	0.00299	CcSEcCtD
Diphenhydramine—Pollakiuria—Epirubicin—stomach cancer	0.00107	0.00297	CcSEcCtD
Diphenhydramine—CYP2B6—lymphoid tissue—stomach cancer	0.00107	0.0193	CbGeAlD
Diphenhydramine—Palpitations—Docetaxel—stomach cancer	0.00106	0.00294	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Epirubicin—stomach cancer	0.00106	0.00294	CcSEcCtD
Diphenhydramine—CYP2B6—digestive system—stomach cancer	0.00106	0.019	CbGeAlD
Diphenhydramine—CYP2C9—digestive system—stomach cancer	0.00104	0.0189	CbGeAlD
Diphenhydramine—Vertigo—Capecitabine—stomach cancer	0.00104	0.00289	CcSEcCtD
Diphenhydramine—Convulsion—Docetaxel—stomach cancer	0.00104	0.00288	CcSEcCtD
Diphenhydramine—Drowsiness—Epirubicin—stomach cancer	0.00103	0.00287	CcSEcCtD
Diphenhydramine—HRH1—digestive system—stomach cancer	0.00103	0.0186	CbGeAlD
Diphenhydramine—Agranulocytosis—Methotrexate—stomach cancer	0.00103	0.00286	CcSEcCtD
Diphenhydramine—Palpitations—Capecitabine—stomach cancer	0.00102	0.00284	CcSEcCtD
Diphenhydramine—Asthenia—Irinotecan—stomach cancer	0.00101	0.00282	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Epirubicin—stomach cancer	0.00101	0.00281	CcSEcCtD
Diphenhydramine—CYP2C19—liver—stomach cancer	0.001	0.0181	CbGeAlD
Diphenhydramine—Dysuria—Doxorubicin—stomach cancer	0.001	0.00278	CcSEcCtD
Diphenhydramine—Dry mouth—Docetaxel—stomach cancer	0.000995	0.00277	CcSEcCtD
Diphenhydramine—Pollakiuria—Doxorubicin—stomach cancer	0.000989	0.00275	CcSEcCtD
Diphenhydramine—Confusional state—Docetaxel—stomach cancer	0.000984	0.00274	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000977	0.00272	CcSEcCtD
Diphenhydramine—Diarrhoea—Irinotecan—stomach cancer	0.000965	0.00269	CcSEcCtD
Diphenhydramine—Dry mouth—Capecitabine—stomach cancer	0.000963	0.00268	CcSEcCtD
Diphenhydramine—Agranulocytosis—Epirubicin—stomach cancer	0.000963	0.00268	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Docetaxel—stomach cancer	0.000955	0.00266	CcSEcCtD
Diphenhydramine—Drowsiness—Doxorubicin—stomach cancer	0.000955	0.00265	CcSEcCtD
Diphenhydramine—PTGS1—digestive system—stomach cancer	0.000954	0.0172	CbGeAlD
Diphenhydramine—Confusional state—Capecitabine—stomach cancer	0.000952	0.00265	CcSEcCtD
Diphenhydramine—Tachycardia—Docetaxel—stomach cancer	0.000952	0.00265	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000936	0.0026	CcSEcCtD
Diphenhydramine—Dizziness—Irinotecan—stomach cancer	0.000933	0.0026	CcSEcCtD
Diphenhydramine—Anorexia—Docetaxel—stomach cancer	0.00093	0.00259	CcSEcCtD
Diphenhydramine—Diarrhoea—Fluorouracil—stomach cancer	0.000925	0.00257	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Capecitabine—stomach cancer	0.000925	0.00257	CcSEcCtD
Diphenhydramine—Tinnitus—Methotrexate—stomach cancer	0.000923	0.00257	CcSEcCtD
Diphenhydramine—Tachycardia—Capecitabine—stomach cancer	0.000922	0.00256	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Capecitabine—stomach cancer	0.000913	0.00254	CcSEcCtD
Diphenhydramine—Hypotension—Docetaxel—stomach cancer	0.000911	0.00253	CcSEcCtD
Diphenhydramine—CYP1A2—endocrine gland—stomach cancer	0.00091	0.0164	CbGeAlD
Diphenhydramine—SLC22A5—liver—stomach cancer	0.000905	0.0163	CbGeAlD
Diphenhydramine—Anorexia—Capecitabine—stomach cancer	0.0009	0.0025	CcSEcCtD
Diphenhydramine—Vomiting—Irinotecan—stomach cancer	0.000897	0.0025	CcSEcCtD
Diphenhydramine—Dizziness—Fluorouracil—stomach cancer	0.000894	0.00249	CcSEcCtD
Diphenhydramine—Agranulocytosis—Doxorubicin—stomach cancer	0.000891	0.00248	CcSEcCtD
Diphenhydramine—Rash—Irinotecan—stomach cancer	0.00089	0.00247	CcSEcCtD
Diphenhydramine—Dermatitis—Irinotecan—stomach cancer	0.000889	0.00247	CcSEcCtD
Diphenhydramine—Chills—Methotrexate—stomach cancer	0.000888	0.00247	CcSEcCtD
Diphenhydramine—Headache—Irinotecan—stomach cancer	0.000884	0.00246	CcSEcCtD
Diphenhydramine—Hypotension—Capecitabine—stomach cancer	0.000882	0.00245	CcSEcCtD
Diphenhydramine—Insomnia—Docetaxel—stomach cancer	0.000882	0.00245	CcSEcCtD
Diphenhydramine—Paraesthesia—Docetaxel—stomach cancer	0.000876	0.00244	CcSEcCtD
Diphenhydramine—CYP2B6—endocrine gland—stomach cancer	0.000872	0.0157	CbGeAlD
Diphenhydramine—Somnolence—Docetaxel—stomach cancer	0.000867	0.00241	CcSEcCtD
Diphenhydramine—Tinnitus—Epirubicin—stomach cancer	0.000863	0.0024	CcSEcCtD
Diphenhydramine—CYP2C9—endocrine gland—stomach cancer	0.000863	0.0156	CbGeAlD
Diphenhydramine—Vomiting—Fluorouracil—stomach cancer	0.000859	0.00239	CcSEcCtD
Diphenhydramine—Dyspepsia—Docetaxel—stomach cancer	0.000859	0.00239	CcSEcCtD
Diphenhydramine—Insomnia—Capecitabine—stomach cancer	0.000854	0.00238	CcSEcCtD
Diphenhydramine—Rash—Fluorouracil—stomach cancer	0.000852	0.00237	CcSEcCtD
Diphenhydramine—HRH1—endocrine gland—stomach cancer	0.000851	0.0154	CbGeAlD
Diphenhydramine—Dermatitis—Fluorouracil—stomach cancer	0.000851	0.00237	CcSEcCtD
Diphenhydramine—Paraesthesia—Capecitabine—stomach cancer	0.000848	0.00236	CcSEcCtD
Diphenhydramine—Decreased appetite—Docetaxel—stomach cancer	0.000848	0.00236	CcSEcCtD
Diphenhydramine—Headache—Fluorouracil—stomach cancer	0.000847	0.00235	CcSEcCtD
Diphenhydramine—Fatigue—Docetaxel—stomach cancer	0.000841	0.00234	CcSEcCtD
Diphenhydramine—Nausea—Irinotecan—stomach cancer	0.000838	0.00233	CcSEcCtD
Diphenhydramine—Constipation—Docetaxel—stomach cancer	0.000834	0.00232	CcSEcCtD
Diphenhydramine—Dyspepsia—Capecitabine—stomach cancer	0.000831	0.00231	CcSEcCtD
Diphenhydramine—Chills—Epirubicin—stomach cancer	0.000831	0.00231	CcSEcCtD
Diphenhydramine—Decreased appetite—Capecitabine—stomach cancer	0.000821	0.00228	CcSEcCtD
Diphenhydramine—CYP1A2—liver—stomach cancer	0.00082	0.0148	CbGeAlD
Diphenhydramine—Fatigue—Capecitabine—stomach cancer	0.000814	0.00226	CcSEcCtD
Diphenhydramine—Vision blurred—Methotrexate—stomach cancer	0.000812	0.00226	CcSEcCtD
Diphenhydramine—Constipation—Capecitabine—stomach cancer	0.000808	0.00225	CcSEcCtD
Diphenhydramine—Feeling abnormal—Docetaxel—stomach cancer	0.000804	0.00224	CcSEcCtD
Diphenhydramine—Nausea—Fluorouracil—stomach cancer	0.000803	0.00223	CcSEcCtD
Diphenhydramine—Tinnitus—Doxorubicin—stomach cancer	0.000799	0.00222	CcSEcCtD
Diphenhydramine—Tension—Epirubicin—stomach cancer	0.000791	0.0022	CcSEcCtD
Diphenhydramine—PTGS1—endocrine gland—stomach cancer	0.000788	0.0142	CbGeAlD
Diphenhydramine—CYP2B6—liver—stomach cancer	0.000786	0.0142	CbGeAlD
Diphenhydramine—CYP2D6—digestive system—stomach cancer	0.000784	0.0141	CbGeAlD
Diphenhydramine—Nervousness—Epirubicin—stomach cancer	0.000783	0.00218	CcSEcCtD
Diphenhydramine—CYP2C9—liver—stomach cancer	0.000778	0.014	CbGeAlD
Diphenhydramine—Feeling abnormal—Capecitabine—stomach cancer	0.000778	0.00216	CcSEcCtD
Diphenhydramine—Vertigo—Methotrexate—stomach cancer	0.000774	0.00215	CcSEcCtD
Diphenhydramine—Chills—Doxorubicin—stomach cancer	0.000769	0.00214	CcSEcCtD
Diphenhydramine—Vision blurred—Epirubicin—stomach cancer	0.00076	0.00211	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP2A6—stomach cancer	0.000752	0.0456	CrCbGaD
Diphenhydramine—Urticaria—Capecitabine—stomach cancer	0.00075	0.00209	CcSEcCtD
Diphenhydramine—Convulsion—Methotrexate—stomach cancer	0.000746	0.00208	CcSEcCtD
Diphenhydramine—Agitation—Epirubicin—stomach cancer	0.000741	0.00206	CcSEcCtD
Diphenhydramine—Tension—Doxorubicin—stomach cancer	0.000732	0.00204	CcSEcCtD
Diphenhydramine—Nervousness—Doxorubicin—stomach cancer	0.000724	0.00201	CcSEcCtD
Diphenhydramine—Vertigo—Epirubicin—stomach cancer	0.000724	0.00201	CcSEcCtD
Diphenhydramine—Palpitations—Epirubicin—stomach cancer	0.000712	0.00198	CcSEcCtD
Diphenhydramine—Confusional state—Methotrexate—stomach cancer	0.000709	0.00197	CcSEcCtD
Diphenhydramine—Vision blurred—Doxorubicin—stomach cancer	0.000703	0.00196	CcSEcCtD
Diphenhydramine—Asthenia—Docetaxel—stomach cancer	0.0007	0.00195	CcSEcCtD
Diphenhydramine—Convulsion—Epirubicin—stomach cancer	0.000698	0.00194	CcSEcCtD
Diphenhydramine—SLC22A5—lymph node—stomach cancer	0.000694	0.0125	CbGeAlD
Diphenhydramine—Thrombocytopenia—Methotrexate—stomach cancer	0.000688	0.00191	CcSEcCtD
Diphenhydramine—Agitation—Doxorubicin—stomach cancer	0.000685	0.00191	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Methotrexate—stomach cancer	0.00068	0.00189	CcSEcCtD
Diphenhydramine—Asthenia—Capecitabine—stomach cancer	0.000678	0.00188	CcSEcCtD
Diphenhydramine—Dry mouth—Epirubicin—stomach cancer	0.000671	0.00187	CcSEcCtD
Diphenhydramine—Vertigo—Doxorubicin—stomach cancer	0.00067	0.00186	CcSEcCtD
Diphenhydramine—Anorexia—Methotrexate—stomach cancer	0.00067	0.00186	CcSEcCtD
Diphenhydramine—Diarrhoea—Docetaxel—stomach cancer	0.000667	0.00186	CcSEcCtD
Diphenhydramine—Confusional state—Epirubicin—stomach cancer	0.000663	0.00185	CcSEcCtD
Diphenhydramine—Palpitations—Doxorubicin—stomach cancer	0.000659	0.00183	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS2—stomach cancer	0.000658	0.0398	CrCbGaD
Diphenhydramine—Hypotension—Methotrexate—stomach cancer	0.000657	0.00183	CcSEcCtD
Diphenhydramine—CYP2D6—endocrine gland—stomach cancer	0.000648	0.0117	CbGeAlD
Diphenhydramine—Convulsion—Doxorubicin—stomach cancer	0.000646	0.0018	CcSEcCtD
Diphenhydramine—Diarrhoea—Capecitabine—stomach cancer	0.000646	0.0018	CcSEcCtD
Diphenhydramine—Dizziness—Docetaxel—stomach cancer	0.000645	0.00179	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Epirubicin—stomach cancer	0.000644	0.00179	CcSEcCtD
Diphenhydramine—Tachycardia—Epirubicin—stomach cancer	0.000642	0.00179	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Epirubicin—stomach cancer	0.000636	0.00177	CcSEcCtD
Diphenhydramine—Insomnia—Methotrexate—stomach cancer	0.000636	0.00177	CcSEcCtD
Diphenhydramine—Paraesthesia—Methotrexate—stomach cancer	0.000631	0.00176	CcSEcCtD
Diphenhydramine—Anorexia—Epirubicin—stomach cancer	0.000627	0.00174	CcSEcCtD
Diphenhydramine—Somnolence—Methotrexate—stomach cancer	0.000625	0.00174	CcSEcCtD
Diphenhydramine—Dizziness—Capecitabine—stomach cancer	0.000625	0.00174	CcSEcCtD
Diphenhydramine—Dry mouth—Doxorubicin—stomach cancer	0.000621	0.00173	CcSEcCtD
Diphenhydramine—Vomiting—Docetaxel—stomach cancer	0.00062	0.00172	CcSEcCtD
Diphenhydramine—Dyspepsia—Methotrexate—stomach cancer	0.000619	0.00172	CcSEcCtD
Diphenhydramine—Rash—Docetaxel—stomach cancer	0.000615	0.00171	CcSEcCtD
Diphenhydramine—Hypotension—Epirubicin—stomach cancer	0.000615	0.00171	CcSEcCtD
Diphenhydramine—Dermatitis—Docetaxel—stomach cancer	0.000614	0.00171	CcSEcCtD
Diphenhydramine—Confusional state—Doxorubicin—stomach cancer	0.000614	0.00171	CcSEcCtD
Diphenhydramine—Decreased appetite—Methotrexate—stomach cancer	0.000611	0.0017	CcSEcCtD
Diphenhydramine—Headache—Docetaxel—stomach cancer	0.000611	0.0017	CcSEcCtD
Diphenhydramine—Fatigue—Methotrexate—stomach cancer	0.000606	0.00169	CcSEcCtD
Diphenhydramine—Vomiting—Capecitabine—stomach cancer	0.0006	0.00167	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000596	0.00166	CcSEcCtD
Diphenhydramine—Rash—Capecitabine—stomach cancer	0.000595	0.00166	CcSEcCtD
Diphenhydramine—Insomnia—Epirubicin—stomach cancer	0.000595	0.00165	CcSEcCtD
Diphenhydramine—Dermatitis—Capecitabine—stomach cancer	0.000595	0.00165	CcSEcCtD
Diphenhydramine—Tachycardia—Doxorubicin—stomach cancer	0.000594	0.00165	CcSEcCtD
Diphenhydramine—Headache—Capecitabine—stomach cancer	0.000592	0.00165	CcSEcCtD
Diphenhydramine—Paraesthesia—Epirubicin—stomach cancer	0.000591	0.00164	CcSEcCtD
Diphenhydramine—HRH1—lymph node—stomach cancer	0.000589	0.0106	CbGeAlD
Diphenhydramine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000589	0.00164	CcSEcCtD
Diphenhydramine—Somnolence—Epirubicin—stomach cancer	0.000585	0.00163	CcSEcCtD
Diphenhydramine—CYP2D6—liver—stomach cancer	0.000584	0.0105	CbGeAlD
Diphenhydramine—Anorexia—Doxorubicin—stomach cancer	0.00058	0.00161	CcSEcCtD
Diphenhydramine—Nausea—Docetaxel—stomach cancer	0.000579	0.00161	CcSEcCtD
Diphenhydramine—Feeling abnormal—Methotrexate—stomach cancer	0.000579	0.00161	CcSEcCtD
Diphenhydramine—Dyspepsia—Epirubicin—stomach cancer	0.000579	0.00161	CcSEcCtD
Diphenhydramine—Decreased appetite—Epirubicin—stomach cancer	0.000572	0.00159	CcSEcCtD
Diphenhydramine—Hypotension—Doxorubicin—stomach cancer	0.000569	0.00158	CcSEcCtD
Diphenhydramine—Fatigue—Epirubicin—stomach cancer	0.000567	0.00158	CcSEcCtD
Diphenhydramine—Constipation—Epirubicin—stomach cancer	0.000563	0.00156	CcSEcCtD
Diphenhydramine—Nausea—Capecitabine—stomach cancer	0.000561	0.00156	CcSEcCtD
Diphenhydramine—Urticaria—Methotrexate—stomach cancer	0.000559	0.00155	CcSEcCtD
Diphenhydramine—Insomnia—Doxorubicin—stomach cancer	0.000551	0.00153	CcSEcCtD
Diphenhydramine—Paraesthesia—Doxorubicin—stomach cancer	0.000547	0.00152	CcSEcCtD
Diphenhydramine—PTGS1—lymph node—stomach cancer	0.000545	0.00983	CbGeAlD
Diphenhydramine—Fenoprofen—PTGS2—stomach cancer	0.000543	0.0329	CrCbGaD
Diphenhydramine—Feeling abnormal—Epirubicin—stomach cancer	0.000542	0.00151	CcSEcCtD
Diphenhydramine—Somnolence—Doxorubicin—stomach cancer	0.000541	0.00151	CcSEcCtD
Diphenhydramine—Dyspepsia—Doxorubicin—stomach cancer	0.000536	0.00149	CcSEcCtD
Diphenhydramine—Decreased appetite—Doxorubicin—stomach cancer	0.000529	0.00147	CcSEcCtD
Diphenhydramine—Phenoxybenzamine—ADRB2—stomach cancer	0.000526	0.0319	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2A6—stomach cancer	0.000526	0.0319	CrCbGaD
Diphenhydramine—Fatigue—Doxorubicin—stomach cancer	0.000525	0.00146	CcSEcCtD
Diphenhydramine—Urticaria—Epirubicin—stomach cancer	0.000523	0.00145	CcSEcCtD
Diphenhydramine—Constipation—Doxorubicin—stomach cancer	0.000521	0.00145	CcSEcCtD
Diphenhydramine—Asthenia—Methotrexate—stomach cancer	0.000504	0.0014	CcSEcCtD
Diphenhydramine—Feeling abnormal—Doxorubicin—stomach cancer	0.000502	0.0014	CcSEcCtD
Diphenhydramine—Fenoprofen—ALB—stomach cancer	0.000484	0.0293	CrCbGaD
Diphenhydramine—Urticaria—Doxorubicin—stomach cancer	0.000484	0.00135	CcSEcCtD
Diphenhydramine—Diarrhoea—Methotrexate—stomach cancer	0.000481	0.00134	CcSEcCtD
Diphenhydramine—Trimipramine—HTR1A—stomach cancer	0.000478	0.029	CrCbGaD
Diphenhydramine—Asthenia—Epirubicin—stomach cancer	0.000472	0.00131	CcSEcCtD
Diphenhydramine—Dizziness—Methotrexate—stomach cancer	0.000465	0.00129	CcSEcCtD
Diphenhydramine—Doxepin—HTR1A—stomach cancer	0.000456	0.0276	CrCbGaD
Diphenhydramine—Diarrhoea—Epirubicin—stomach cancer	0.00045	0.00125	CcSEcCtD
Diphenhydramine—Vomiting—Methotrexate—stomach cancer	0.000447	0.00124	CcSEcCtD
Diphenhydramine—Rash—Methotrexate—stomach cancer	0.000443	0.00123	CcSEcCtD
Diphenhydramine—Dermatitis—Methotrexate—stomach cancer	0.000443	0.00123	CcSEcCtD
Diphenhydramine—Headache—Methotrexate—stomach cancer	0.00044	0.00122	CcSEcCtD
Diphenhydramine—Asthenia—Doxorubicin—stomach cancer	0.000437	0.00121	CcSEcCtD
Diphenhydramine—Dizziness—Epirubicin—stomach cancer	0.000435	0.00121	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS2—stomach cancer	0.000435	0.0263	CrCbGaD
Diphenhydramine—Vomiting—Epirubicin—stomach cancer	0.000418	0.00116	CcSEcCtD
Diphenhydramine—Nausea—Methotrexate—stomach cancer	0.000418	0.00116	CcSEcCtD
Diphenhydramine—Phenprocoumon—ALB—stomach cancer	0.000417	0.0253	CrCbGaD
Diphenhydramine—Diarrhoea—Doxorubicin—stomach cancer	0.000417	0.00116	CcSEcCtD
Diphenhydramine—Rash—Epirubicin—stomach cancer	0.000415	0.00115	CcSEcCtD
Diphenhydramine—Dermatitis—Epirubicin—stomach cancer	0.000414	0.00115	CcSEcCtD
Diphenhydramine—Headache—Epirubicin—stomach cancer	0.000412	0.00115	CcSEcCtD
Diphenhydramine—Dizziness—Doxorubicin—stomach cancer	0.000403	0.00112	CcSEcCtD
Diphenhydramine—Nausea—Epirubicin—stomach cancer	0.000391	0.00109	CcSEcCtD
Diphenhydramine—Vomiting—Doxorubicin—stomach cancer	0.000387	0.00108	CcSEcCtD
Diphenhydramine—Rash—Doxorubicin—stomach cancer	0.000384	0.00107	CcSEcCtD
Diphenhydramine—Dermatitis—Doxorubicin—stomach cancer	0.000383	0.00107	CcSEcCtD
Diphenhydramine—Headache—Doxorubicin—stomach cancer	0.000381	0.00106	CcSEcCtD
Diphenhydramine—Warfarin—ALB—stomach cancer	0.00037	0.0224	CrCbGaD
Diphenhydramine—Nausea—Doxorubicin—stomach cancer	0.000362	0.00101	CcSEcCtD
Diphenhydramine—Imipramine—HTR1A—stomach cancer	0.000355	0.0215	CrCbGaD
Diphenhydramine—Amitriptyline—HTR1A—stomach cancer	0.000352	0.0213	CrCbGaD
Diphenhydramine—Phenytoin—ALB—stomach cancer	0.000269	0.0163	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—stomach cancer	0.000158	0.00958	CrCbGaD
Diphenhydramine—CYP2B6—Metabolism—CD44—stomach cancer	3.72e-05	0.000179	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RPS6—stomach cancer	3.67e-05	0.000177	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PRKCB—stomach cancer	3.67e-05	0.000177	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6ST—stomach cancer	3.65e-05	0.000176	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TYMS—stomach cancer	3.63e-05	0.000175	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ERCC2—stomach cancer	3.62e-05	0.000175	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	3.61e-05	0.000174	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.6e-05	0.000173	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	3.59e-05	0.000173	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GSTM1—stomach cancer	3.59e-05	0.000173	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.59e-05	0.000173	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALOX5—stomach cancer	3.58e-05	0.000173	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—NOS3—stomach cancer	3.58e-05	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALOX5—stomach cancer	3.55e-05	0.000171	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SREBF2—stomach cancer	3.52e-05	0.00017	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DPYD—stomach cancer	3.52e-05	0.00017	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ERCC2—stomach cancer	3.52e-05	0.000169	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DPYD—stomach cancer	3.49e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RORA—stomach cancer	3.48e-05	0.000168	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.47e-05	0.000167	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HBEGF—stomach cancer	3.42e-05	0.000165	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MTHFR—stomach cancer	3.4e-05	0.000164	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTT1—stomach cancer	3.38e-05	0.000163	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ERCC2—stomach cancer	3.37e-05	0.000163	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HBEGF—stomach cancer	3.37e-05	0.000162	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.35e-05	0.000161	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MTHFR—stomach cancer	3.3e-05	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—stomach cancer	3.27e-05	0.000158	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALDOB—stomach cancer	3.26e-05	0.000157	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6R—stomach cancer	3.26e-05	0.000157	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.25e-05	0.000157	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—RHOA—stomach cancer	3.24e-05	0.000156	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6R—stomach cancer	3.2e-05	0.000155	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	3.19e-05	0.000154	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—stomach cancer	3.17e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ENO1—stomach cancer	3.17e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPP2R1A—stomach cancer	3.16e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.16e-05	0.000152	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRB2—stomach cancer	3.16e-05	0.000152	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CAV1—stomach cancer	3.14e-05	0.000151	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOA1—stomach cancer	3.13e-05	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.12e-05	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTT1—stomach cancer	3.11e-05	0.00015	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRB2—stomach cancer	3.11e-05	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—stomach cancer	3.1e-05	0.00015	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	3.1e-05	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTT1—stomach cancer	3.09e-05	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CYP2A6—stomach cancer	3.08e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.07e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.07e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HMOX1—stomach cancer	3.06e-05	0.000148	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CYP2A6—stomach cancer	3.05e-05	0.000147	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CAV1—stomach cancer	3.05e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	3.05e-05	0.000147	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOA1—stomach cancer	3.04e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALOX5—stomach cancer	3.03e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.99e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DPYD—stomach cancer	2.98e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKR1C3—stomach cancer	2.97e-05	0.000143	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RHOA—stomach cancer	2.94e-05	0.000142	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CAV1—stomach cancer	2.93e-05	0.000141	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOA1—stomach cancer	2.92e-05	0.000141	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ENO1—stomach cancer	2.92e-05	0.000141	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.91e-05	0.00014	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RHOA—stomach cancer	2.89e-05	0.00014	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ENO1—stomach cancer	2.89e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TYMS—stomach cancer	2.89e-05	0.000139	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SMAD4—stomach cancer	2.87e-05	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—stomach cancer	2.85e-05	0.000138	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	2.84e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.84e-05	0.000137	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SMAD4—stomach cancer	2.83e-05	0.000136	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CD44—stomach cancer	2.81e-05	0.000136	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	2.8e-05	0.000135	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—stomach cancer	2.76e-05	0.000133	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FYN—stomach cancer	2.73e-05	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.73e-05	0.000132	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.7e-05	0.00013	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FYN—stomach cancer	2.69e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ERCC2—stomach cancer	2.68e-05	0.000129	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—stomach cancer	2.68e-05	0.000129	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTT1—stomach cancer	2.64e-05	0.000127	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2A6—stomach cancer	2.61e-05	0.000126	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD44—stomach cancer	2.59e-05	0.000125	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—stomach cancer	2.58e-05	0.000125	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—stomach cancer	2.57e-05	0.000124	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD44—stomach cancer	2.56e-05	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGFR2—stomach cancer	2.56e-05	0.000124	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	2.54e-05	0.000123	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.54e-05	0.000122	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—stomach cancer	2.52e-05	0.000122	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGFR2—stomach cancer	2.52e-05	0.000122	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.49e-05	0.00012	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—stomach cancer	2.48e-05	0.00012	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ENO1—stomach cancer	2.47e-05	0.000119	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.43e-05	0.000117	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—stomach cancer	2.41e-05	0.000116	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.39e-05	0.000115	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NOS3—stomach cancer	2.37e-05	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IRS2—stomach cancer	2.35e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—stomach cancer	2.35e-05	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CAV1—stomach cancer	2.33e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOA1—stomach cancer	2.32e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—stomach cancer	2.31e-05	0.000112	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—stomach cancer	2.31e-05	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IRS2—stomach cancer	2.31e-05	0.000111	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—stomach cancer	2.3e-05	0.000111	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CAV1—stomach cancer	2.27e-05	0.00011	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOA1—stomach cancer	2.27e-05	0.000109	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CAV1—stomach cancer	2.24e-05	0.000108	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOA1—stomach cancer	2.23e-05	0.000108	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—stomach cancer	2.21e-05	0.000107	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPP2R1A—stomach cancer	2.2e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD44—stomach cancer	2.19e-05	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TYMS—stomach cancer	2.18e-05	0.000105	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPP2R1A—stomach cancer	2.18e-05	0.000105	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—stomach cancer	2.17e-05	0.000105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKCB—stomach cancer	2.17e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—stomach cancer	2.16e-05	0.000104	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6ST—stomach cancer	2.16e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—stomach cancer	2.16e-05	0.000104	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—stomach cancer	2.14e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCB—stomach cancer	2.13e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—stomach cancer	2.13e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.13e-05	0.000103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6ST—stomach cancer	2.12e-05	0.000102	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—stomach cancer	2.11e-05	0.000102	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—stomach cancer	2.11e-05	0.000102	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—stomach cancer	2.07e-05	9.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—stomach cancer	2.04e-05	9.86e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—stomach cancer	2.04e-05	9.83e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ERCC2—stomach cancer	2.03e-05	9.77e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—stomach cancer	2.02e-05	9.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—stomach cancer	2.01e-05	9.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TYMS—stomach cancer	2.01e-05	9.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TYMS—stomach cancer	1.99e-05	9.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—stomach cancer	1.98e-05	9.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—stomach cancer	1.98e-05	9.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—stomach cancer	1.97e-05	9.48e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	1.95e-05	9.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6R—stomach cancer	1.92e-05	9.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—stomach cancer	1.91e-05	9.18e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6R—stomach cancer	1.89e-05	9.13e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK1—stomach cancer	1.89e-05	9.1e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—stomach cancer	1.89e-05	9.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ERCC2—stomach cancer	1.86e-05	8.99e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.86e-05	8.98e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	1.86e-05	8.96e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—stomach cancer	1.86e-05	8.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ERCC2—stomach cancer	1.85e-05	8.91e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—stomach cancer	1.84e-05	8.86e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—stomach cancer	1.83e-05	8.81e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.8e-05	8.7e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—stomach cancer	1.8e-05	8.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.8e-05	8.69e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.78e-05	8.6e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	1.78e-05	8.56e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	1.77e-05	8.55e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—stomach cancer	1.76e-05	8.48e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAV1—stomach cancer	1.76e-05	8.47e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—stomach cancer	1.75e-05	8.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOA1—stomach cancer	1.75e-05	8.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—stomach cancer	1.75e-05	8.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RHOA—stomach cancer	1.74e-05	8.38e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—stomach cancer	1.74e-05	8.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—stomach cancer	1.72e-05	8.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RHOA—stomach cancer	1.71e-05	8.24e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TYMS—stomach cancer	1.7e-05	8.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—stomach cancer	1.69e-05	8.16e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—stomach cancer	1.68e-05	8.1e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.68e-05	8.09e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	1.64e-05	7.9e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAV1—stomach cancer	1.62e-05	7.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOA1—stomach cancer	1.61e-05	7.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	1.61e-05	7.77e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—stomach cancer	1.61e-05	7.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—stomach cancer	1.61e-05	7.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAV1—stomach cancer	1.6e-05	7.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOA1—stomach cancer	1.6e-05	7.71e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—stomach cancer	1.58e-05	7.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ERCC2—stomach cancer	1.58e-05	7.61e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—stomach cancer	1.54e-05	7.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.53e-05	7.38e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—stomach cancer	1.53e-05	7.36e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRAS—stomach cancer	1.52e-05	7.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	1.5e-05	7.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	1.49e-05	7.19e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	1.49e-05	7.18e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—stomach cancer	1.48e-05	7.16e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	1.47e-05	7.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—stomach cancer	1.45e-05	6.99e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—stomach cancer	1.43e-05	6.88e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCND1—stomach cancer	1.42e-05	6.85e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—stomach cancer	1.42e-05	6.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—JUN—stomach cancer	1.42e-05	6.84e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—stomach cancer	1.41e-05	6.79e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCND1—stomach cancer	1.4e-05	6.74e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—JUN—stomach cancer	1.4e-05	6.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—stomach cancer	1.39e-05	6.7e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—stomach cancer	1.38e-05	6.65e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	1.38e-05	6.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAV1—stomach cancer	1.37e-05	6.6e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOA1—stomach cancer	1.37e-05	6.59e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—stomach cancer	1.36e-05	6.55e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	1.35e-05	6.52e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—stomach cancer	1.34e-05	6.47e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—stomach cancer	1.34e-05	6.44e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—stomach cancer	1.33e-05	6.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	1.32e-05	6.37e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.31e-05	6.31e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—stomach cancer	1.3e-05	6.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—stomach cancer	1.28e-05	6.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—stomach cancer	1.27e-05	6.11e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—stomach cancer	1.25e-05	6e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—stomach cancer	1.24e-05	5.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—stomach cancer	1.23e-05	5.92e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—stomach cancer	1.22e-05	5.89e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	1.22e-05	5.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—stomach cancer	1.22e-05	5.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—stomach cancer	1.21e-05	5.84e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—stomach cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—stomach cancer	1.2e-05	5.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—stomach cancer	1.17e-05	5.65e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	1.15e-05	5.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—stomach cancer	1.14e-05	5.5e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—stomach cancer	1.12e-05	5.41e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—stomach cancer	1.12e-05	5.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK1—stomach cancer	1.12e-05	5.38e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—stomach cancer	1.12e-05	5.38e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—stomach cancer	1.11e-05	5.34e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	1.1e-05	5.29e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—stomach cancer	1.1e-05	5.29e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—stomach cancer	1.08e-05	5.22e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—stomach cancer	1.05e-05	5.08e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—stomach cancer	1.04e-05	5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—stomach cancer	1.04e-05	4.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—stomach cancer	9.89e-06	4.77e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	9.68e-06	4.67e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	9.52e-06	4.59e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—stomach cancer	9.47e-06	4.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—stomach cancer	9.36e-06	4.51e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—stomach cancer	9.21e-06	4.44e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRAS—stomach cancer	8.95e-06	4.32e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRAS—stomach cancer	8.81e-06	4.25e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—stomach cancer	8.57e-06	4.13e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—stomach cancer	8.43e-06	4.07e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—stomach cancer	7.48e-06	3.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—stomach cancer	6.88e-06	3.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—stomach cancer	6.82e-06	3.29e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—stomach cancer	5.83e-06	2.81e-05	CbGpPWpGaD
